Insider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 5,995 Shares of Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Nitin Kaushal sold 5,995 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total transaction of $51,437.10. Following the completion of the sale, the director now directly owns 126,843 shares of the company’s stock, valued at approximately $1,088,312.94. This trade represents a 4.51 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Nitin Kaushal also recently made the following trade(s):

• On Monday, November 11th, Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.56, for a total value of $286,800.00.

Viemed Healthcare Stock Performance

Shares of VMD traded up $0.01 on Tuesday, reaching $8.66. 107,592 shares of the stock traded hands, compared to its average volume of 153,692. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The stock’s 50-day moving average price is $8.51 and its 200-day moving average price is $7.57. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The firm has a market cap of $337.22 million, a price-to-earnings ratio of 32.04 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million during the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Hedge Funds Weigh In On Viemed Healthcare

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in Viemed Healthcare by 53.0% during the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares during the period. Apis Capital Advisors LLC increased its position in shares of Viemed Healthcare by 193.0% during the second quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock worth $1,535,000 after acquiring an additional 154,400 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Viemed Healthcare by 5.3% in the 1st quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock valued at $1,386,000 after acquiring an additional 7,386 shares in the last quarter. Price T Rowe Associates Inc. MD bought a new position in shares of Viemed Healthcare during the first quarter worth about $97,000. Finally, Oppenheimer Asset Management Inc. increased its stake in Viemed Healthcare by 5.6% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock valued at $222,000 after buying an additional 1,601 shares during the last quarter. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.